KRT18P37

Across TCGA pan-cancer cohorts, KRT18P37 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of KRT18P37’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where KRT18P37 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRT18P37 is over-expressed in tumor, although a few such as KICH and HNSC show the opposite, repressed pattern.

BLCA, COAD, and KIRC are the cancer types where KRT18P37 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRT18P37 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	+0.117	<.001	11	view →
COAD	All	II,III,IV	+0.297	.002	8	view →
KIRC	All	III,IV	+0.043	.002	6	view →
LUAD	All	All	+0.107	<.001	5	view →
KIRP	All	All	+0.090	.001	5	view →
BRCA	All	All	+0.053	.007	4	view →
CHOL	All	All	+0.174	.001	3	view →
STAD	All	All	+0.119	.012	2	view →
HNSC	Male	III,IV	+0.076	.005	2	view →
PRAD	All	All	+0.053	.008	2	view →
LUSC	All	All	+0.045	.031	2	view →
KICH	All	All	−0.059	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

KRT18P37–BLCA

Open the BLCA breakdown →